{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:26:19Z","timestamp":1767896779833,"version":"3.49.0"},"reference-count":273,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1054\/ghir.2001.0263","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T17:51:53Z","timestamp":1027878713000},"page":"1-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Growth hormone replacement therapy for adults: Into the new millennium"],"prefix":"10.1054","volume":"12","author":[{"given":"Helen","family":"Simpson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Savine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"S\u00f6nksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt-\u00c5ke","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Sandahl","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Clemmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinchus Cohen.","family":"Raymond Hintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Primus","family":"Mullis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Strasburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Thorner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/ghir.2001.0263_RF1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2001.0263_RF2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1054\/ghir.2001.0263_RF3","series-title":"Clinical Endocrinology","author":"Besser","year":"1984"},{"key":"10.1054\/ghir.2001.0263_RF4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM196201112660207","article-title":"Clinical use of human growth hormone","volume":"266","author":"Raben","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2001.0263_RF5","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effect of 10 years recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000181583","article-title":"Replacement therapy in hypothalamo-pituitary insufficiency after childhood: management in the adult","volume":"33","author":"S\u00f6nksen","year":"1990","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2001.0263_RF7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1054\/ghir.2001.0263_RF8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/edrv-8-2-115","article-title":"Effect of growth hormone on carbohydrate and lipid metabolism","volume":"8","author":"Davidson","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1054\/ghir.2001.0263_RF9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dmr.5610040406","article-title":"Growth hormone and metabolism","volume":"4","author":"Press","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"10.1054\/ghir.2001.0263_RF10","first-page":"341","article-title":"The effect of human growth hormone in man","volume":"32","author":"Ikkos","year":"1959","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"De Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1054\/ghir.2001.0263_RF12","first-page":"309","article-title":"Treatment of adults with growth hormone deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.ATV.15.10.1543","article-title":"Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement","volume":"15","author":"Snel","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1054\/ghir.2001.0263_RF14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.1994.tb02451.x","article-title":"Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone","volume":"40","author":"Chong","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF17","first-page":"3762","article-title":"Effects of 7 years of growth hormone therapy in hypopituitary adults","volume":"85","author":"Chrisoulidou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1530\/eje.0.1330445","article-title":"Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy","volume":"133","author":"Snel","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF19","first-page":"72","article-title":"Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism","volume":"80","author":"Hoffman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","article-title":"Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1993.tb00974.x","article-title":"Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency","volume":"38","author":"Rosen","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF22","first-page":"1671","article-title":"Body composition, bone metabolism and heart structure and function in growth hormone-deficient adults before and after GH replacement therapy at low doses","volume":"77","author":"Amato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF23","first-page":"833","article-title":"Body composition in adult growth deficient men assessed by anthropometry and bioimpedance analysis","volume":"75","author":"De Boer","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.289.6454.1257","article-title":"Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden","volume":"289","author":"Lapidus","year":"1984","journal-title":"Br Med J"},{"key":"10.1054\/ghir.2001.0263_RF25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2265.1996.728550.x","article-title":"Decreased plasma and extracellular volume in growth hormone-deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study","volume":"44","author":"Moller","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF26","first-page":"1123","article-title":"Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure","volume":"81","author":"Hoffman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF27","first-page":"2069","article-title":"The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis","volume":"80","author":"De Boer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF28","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass and plasma volume adults with growth hormone deficiency","volume":"82","author":"Christ","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1992.tb02358.x","article-title":"Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy","volume":"37","author":"Orme","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/cs0860233","article-title":"Effect of recombinant human growth hormone on cellular sodium metabolism","volume":"86","author":"Herlitz","year":"1994","journal-title":"Clin Sci"},{"key":"10.1054\/ghir.2001.0263_RF31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1530\/eje.0.1300224","article-title":"Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance","volume":"130","author":"Jorgensen","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2265.1995.tb00536.x","article-title":"Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study","volume":"43","author":"Hansen","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","article-title":"Replacement therapy with biosynthestic human growth hormone in growth hormone-deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/j.1550-8528.1996.tb00511.x","article-title":"Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment","volume":"4","author":"Lonn","year":"1996","journal-title":"Obes Res"},{"key":"10.1054\/ghir.2001.0263_RF35","first-page":"3","article-title":"Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency","volume":"4","author":"Johansson","year":"1996","journal-title":"Endocrinol Metabolism"},{"key":"10.1054\/ghir.2001.0263_RF36","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","article-title":"Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset of growth hormone deficiency. A randomized, placebo-controlled trial","volume":"125","author":"Baum","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1054\/ghir.2001.0263_RF38","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass and plasma volume in adults with growth hormone deficiency","volume":"82","author":"Christ","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF39","first-page":"82","article-title":"Adult growth hormone-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF40","first-page":"2373","article-title":"Long-term effects of growth hormone (GH) replacement in men with childhood onset GH deficiency","volume":"84","author":"Ter Maaten","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF41","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulinsensitivity, glucose effectiveness, and body composition in GH-deficient adults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1749-6632.2000.tb06519.x","article-title":"Effect of recombinant human growth hormone on regional tissue distribution in growth hormone-deficient adults","volume":"904","author":"Bell","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1054\/ghir.2001.0263_RF43","first-page":"4104","article-title":"Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease","volume":"85","author":"Fernholm","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF01797616","article-title":"Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: is there a need for additional growth hormone substitution?","volume":"69","author":"W\u00fcster","year":"1991","journal-title":"Klin Wochenschr"},{"key":"10.1054\/ghir.2001.0263_RF45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture rate in adults with hypopituitarism and growth hormone deficiency","volume":"137","author":"Rosen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"Wuster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1054\/ghir.2001.0263_RF47","first-page":"2015","article-title":"Different approaches to bone densitometry","volume":"41","author":"Fogelman","year":"2000","journal-title":"A review. J Nucl Med"},{"key":"10.1054\/ghir.2001.0263_RF48","first-page":"118","article-title":"Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary insuficiencies of childhood onset","volume":"74","author":"Kaufman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF49","first-page":"1344","article-title":"Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency","volume":"76","author":"O'Halloran","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00298715","article-title":"Low bone mineral density in adults with previous hypothalamic-pituitary tumors; correlation with GH responses to GHRH, IGF-I and IGFBP-3","volume":"52","author":"Bing-You","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1054\/ghir.2001.0263_RF51","first-page":"41","article-title":"Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adult growth hormone deficiency","volume":"128","author":"Thoren","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jbmr.5650090822","article-title":"Consequences of childhood-onset growth hormone deficiency for adult bone mass","volume":"9","author":"De Boer","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1054\/ghir.2001.0263_RF53","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF54","first-page":"727","article-title":"Reduced bone mineral content in adult patients with growth hormone deficiency","volume":"132","author":"Rosen","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1530\/eje.0.1330180","article-title":"Reduced bone mineral density in adults with growth hormone deficiency: increased bone turnover during 12 months of GH substitution","volume":"133","author":"Degerblad","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1530\/eje.0.1360282","article-title":"Effects of GH replacement on bone metabolism and mineral density in adult onset GH deficiency: results of double blind placebo-controlled study with open follow up","volume":"136","author":"Finkenstedt","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF57","first-page":"1462","article-title":"Elderly patients with adult-onset GH deficiency are not osteopenic","volume":"82","author":"Toogood","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-978591","article-title":"Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement","volume":"32","author":"Gomez","year":"2000","journal-title":"Horm Metab Res"},{"key":"10.1054\/ghir.2001.0263_RF59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(05)83484-5","article-title":"Effects of long term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency","volume":"122","author":"Saggese","year":"1993","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2001.0263_RF60","first-page":"1919","article-title":"Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF61","first-page":"201","article-title":"Reduced bone mineral content in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol (Copen)"},{"key":"10.1054\/ghir.2001.0263_RF62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2265.1993.tb02387.x","article-title":"Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males","volume":"39","author":"Vandeweghe","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.1994.tb03936.x","article-title":"The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism","volume":"40","author":"Beshyah","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2265.1995.tb01872.x","article-title":"The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF65","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2265.1995.tb02690.x","article-title":"Effect of growth hormone replacement on bone mass in adults with adult-onset growth hormone deficiency","volume":"42","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1530\/eje.0.1320042","article-title":"Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy","volume":"132","author":"Balducci","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF67","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF68","first-page":"3352","article-title":"Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study","volume":"81","author":"Hansen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.1996.tb02056.x","article-title":"Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects","volume":"45","author":"Amato","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2265.1998.00405.x","article-title":"Serum collagen cross-links as markers of bone turnover during GH replacement therapy in growth hormone deficient adults","volume":"48","author":"Rodriguez-Arnao","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2265.1998.00439.x","article-title":"Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults","volume":"48","author":"Kann","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.1998.00465.x","article-title":"Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy","volume":"48","author":"Rahim","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF73","first-page":"970","article-title":"Withdrawl of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency","volume":"85","author":"Biller","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The influence of gender on the short and long term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study","volume":"54","author":"Drake","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/eje.0.1310041","article-title":"Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein 3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset","volume":"131","author":"Juul","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002239900392","article-title":"Effect of long-term growth hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency","volume":"62","author":"Kotzman","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1054\/ghir.2001.0263_RF77","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/jcem-70-4-916","article-title":"Effects of growth hormone on bone Gla protein in GH-deficient adults","volume":"70","author":"Johansen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF78","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/BF03348952","article-title":"Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover","volume":"16","author":"Sartorio","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"10.1054\/ghir.2001.0263_RF79","first-page":"103","article-title":"Replacement therapy with recombinant human growth hormone in GH-deficient adults. Effects on bone metabolism and bone mineral density in a 2-year prospective study","volume":"2","author":"Kann","year":"1995","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF80","first-page":"55","article-title":"The effect of low-dose growth hormone on indices of bone remodelling and bone mineral density in hypopituitary adults","volume":"3","author":"Weaver","year":"1996","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF81","first-page":"1686","article-title":"Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid and calcium metabolism","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF82","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1210\/jcem.82.6.3982","article-title":"The effect of growth hormone (GH) or histomorphometrin indices of bone structure and bone turnover in GH deficient men","volume":"82","author":"Bravenboer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1359\/jbmr.2000.15.2.293","article-title":"Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: a 1-year, double-blind, randomized, placebo-controlled study","volume":"15","author":"Brixen","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1054\/ghir.2001.0263_RF84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000181585","article-title":"Skeletal muscle performance in adults with growth hormone deficiency","volume":"33","author":"Cuneo","year":"1990","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2001.0263_RF85","first-page":"41","article-title":"Quadriceps strength before and after growth hormone replacement in hypopituitary adults: relationship to changes in lean body mass and IGF-I","volume":"1","author":"Rutherford","year":"1994","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF86","first-page":"279","article-title":"Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency","volume":"84","author":"Janssen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.1999.00737.x","article-title":"Effects of growth hormone replacement on physical performance and body composition in GH deficient adults","volume":"51","author":"Rodriguez-Arnao","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF88","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1530\/eje.0.1410342","article-title":"Effect of 6 months of GH treatment on myosin heavy chain composition in GH-deficient patients","volume":"141","author":"Daugaard","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF89","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/adc.67.12.1472","article-title":"Growth hormone deficiency during puberty reduces adult bone mineral density","volume":"67","author":"Hyer","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1054\/ghir.2001.0263_RF90","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1054\/ghir.2001.0263_RF91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.1997.2801076.x","article-title":"Quality of life and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years","volume":"47","author":"Wallymahed","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF92","first-page":"4570","article-title":"Measures of submaximal aerobic exercise performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults","volume":"84","author":"Woodhouse","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF93","first-page":"185","article-title":"Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency","volume":"123","author":"Degerblad","year":"1990","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF94","first-page":"449","article-title":"Long-term growth hormone treatment in growth hormone deficient adults","volume":"125","author":"Jorgensen","year":"1991","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF95","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1054\/ghir.2001.0263_RF96","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1054\/ghir.1999.0112","article-title":"Maximum anaerobic performance of childhood onset GH-deficient adults","volume":"9","author":"Narici","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1054\/ghir.2001.0263_RF97","first-page":"552","article-title":"Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood","volume":"80","author":"Nass","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF98","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1096-6374(98)80307-9","article-title":"Exercise capacity and hormonal response in adults with childhood onset growth hormone deficiency during long-term somatotropin treatment","volume":"8","author":"Gullestad","year":"1998","journal-title":"Growth Horm IGF Res"},{"key":"10.1054\/ghir.2001.0263_RF99","first-page":"219","article-title":"Exercise physiology in health and disease","volume":"112","author":"Wasserman","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1054\/ghir.2001.0263_RF100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V39.2.238.238","article-title":"Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone","volume":"39","author":"Jepson","year":"1972","journal-title":"Blood"},{"key":"10.1054\/ghir.2001.0263_RF101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/jcem-65-1-78","article-title":"Insulin-like growth factor-I stimulates human erythroid colony formation in vitro","volume":"65","author":"Claustres","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF102","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2141.1988.tb02480.x","article-title":"Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor-I","volume":"70","author":"Merchav","year":"1988","journal-title":"Brti J Haematol"},{"key":"10.1054\/ghir.2001.0263_RF103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituiatarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF104","first-page":"1169","article-title":"The effect of hyopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF105","first-page":"OC9","article-title":"Increased mortality in hypopituiarism is not due to an increase in vascular mortality","volume":"152","author":"Bates","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF106","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1054\/ghir.2001.0263_RF107","first-page":"574","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors","volume":"85","author":"Bulow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","article-title":"Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults","volume":"136","author":"Markussis","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF109","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jcem.82.5.3951","article-title":"Increased arterial intima-media thickness in childhood onset growth hormone deficiency","volume":"82","author":"Capaldo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF110","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.1994.78","article-title":"Direct demonstration of insulin-like growth factor I induced nitric oxide production by endothelial cells","volume":"45","author":"Tsukahara","year":"1994","journal-title":"Kidney Int"},{"key":"10.1054\/ghir.2001.0263_RF112","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the haemodynamic effects of recombinant human GH in patients with acquired GHD","volume":"98","author":"Boger","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1054\/ghir.2001.0263_RF113","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.1999.00671.x","article-title":"Endothelial dysfunction in hypopituitary adults with growth hormone deficiency","volume":"50","author":"Evans","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF114","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/hrt.67.1.92","article-title":"Myocardial dysfunction in treated adult hypopituitarism a possible explanation for increased cardiovascular mortality","volume":"67","author":"Shahi","year":"1992","journal-title":"Br Heart J"},{"key":"10.1054\/ghir.2001.0263_RF116","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2265.1994.tb01827.x","article-title":"Short and long-term cardiovascular effect of growth hormone therapy in growth hormone deficient adults","volume":"41","author":"Thuesen","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF117","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM197806012982202","article-title":"A follow up study of vascular disease in growth hormone deficient dwarfs with diabetes","volume":"298","author":"Merimee","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2001.0263_RF118","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1054\/ghir.2001.0263_RF119","first-page":"1658","article-title":"Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency","volume":"77","author":"Merola","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF120","first-page":"659","article-title":"Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment","volume":"80","author":"Valcavi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF121","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","article-title":"Cardiovascular and renal effects of growth hormone","volume":"40","author":"Caidahl","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF122","first-page":"E219","article-title":"Impaired cardiac performance in growth hormone deficient adults and its improvement after growth hormone replacement","volume":"267","author":"Cittadini","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1054\/ghir.2001.0263_RF123","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1210\/jcem.84.11.6112","article-title":"Impaired cardiac performance in elderly patients with growth hormone deficiency","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF124","first-page":"628","article-title":"Abnormal heart rate variability in adults with growth hormone deficiency","volume":"85","author":"Leong","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF125","first-page":"1881","article-title":"Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency","volume":"83","author":"Sverrisd\u00f3ttir","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF126","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0735-1097(94)90738-2","article-title":"Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure","volume":"23","author":"Kaye","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1054\/ghir.2001.0263_RF127","first-page":"1","article-title":"Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation","volume":"3","author":"Rundquist","year":"1997","journal-title":"J Cardiac Failure"},{"key":"10.1054\/ghir.2001.0263_RF128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1096-6374(99)80006-9","article-title":"Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment","volume":"9","author":"Pfeifer","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1054\/ghir.2001.0263_RF129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1999.00805.x","article-title":"Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity","volume":"51","author":"Christ","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF130","first-page":"4683","article-title":"Growth hormone (GH) treatment decreases post-prandial remnant-like particle cholesterol concentration and improves endothelial function in adult onset GH deficiency","volume":"85","author":"Twickler","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1300451","article-title":"Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults","volume":"130","author":"Beshyah","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF132","first-page":"422","article-title":"Treatment with recombinant human growth hormone (rhGH) increases fibrinolysis in GH-deficient adults","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1054\/ghir.2001.0263_RF133","first-page":"1874","article-title":"Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency","volume":"86","author":"Colao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01247366","article-title":"Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionucleotide angiography","volume":"23","author":"Cuocolo","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1054\/ghir.2001.0263_RF135","first-page":"1518","article-title":"Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF136","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1054\/ghir.2001.0263_RF137","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.1999.00751.x","article-title":"Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double blind placebo-controlled study","volume":"51","author":"Christ","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF138","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/ajcn\/33.11.2372","article-title":"A reanalysis of the factors influencing basal metabolic rate in normal adults","volume":"33","author":"Cunningham","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/ghir.2001.0263_RF139","first-page":"237","article-title":"Basal metabolic rate in relation to body size and cell mass in acromegaly","volume":"21","author":"Ikkos","year":"1956","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF140","first-page":"381","article-title":"Body composition and energy expenditure in acromegaly","volume":"78","author":"O'Sullivan","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF141","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/cs0870201","article-title":"Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency","volume":"87","author":"Salomon","year":"1994","journal-title":"Clin Sci"},{"key":"10.1054\/ghir.2001.0263_RF142","first-page":"48","article-title":"Resting metabolic rate in growth hormone deficient adults. Program of the Fourth International Meeting on Growth Hormone Deficiency in Adults","author":"Snel","year":"1993","journal-title":"Cannes, France"},{"key":"10.1054\/ghir.2001.0263_RF143","first-page":"121","article-title":"Protein, fat and glucose metabolism during treatment with recombinant human growth hormone in adults with growth hormone deficiency. Short and long term effects","volume":"4","author":"Salomon","year":"1997","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF144","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","article-title":"Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults","volume":"41","author":"Jorgensen","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism","volume":"69","author":"Jorgensen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF146","first-page":"1392","article-title":"Response of fat cells to growth hormone (GH): effect of long term treatment with recombinant human GH in GH-deficient adults","volume":"78","author":"Harant","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF147","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1172\/JCI117427","article-title":"Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans","volume":"94","author":"Hussain","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1054\/ghir.2001.0263_RF148","first-page":"1589","article-title":"Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects","volume":"77","author":"Jorgensen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF149","first-page":"158","article-title":"Whole-body leucine turnover in adults on conventional treatment for hypopituitarism","volume":"129","author":"Beshyah","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1993.tb00525.x","article-title":"The effects of growth hormone on protein metabolism in adult growth hormone deficient patients","volume":"38","author":"Russell-Jones","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF151","first-page":"4344","article-title":"How is whole body protein turnover perturbed in growth hormone-deficient adults?","volume":"83","author":"Hoffman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF152","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2265.1994.tb02551.x","article-title":"Glucose and fat metabolism in adults with growth hormone deficiency","volume":"41","author":"Salomon","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF153","series-title":"Insulin resistance in GH-deficient adult patients treated with growth hormone: Evidence for a postbinding defect in vivo","first-page":"41","author":"Karnieli","year":"1993"},{"key":"10.1054\/ghir.2001.0263_RF154","first-page":"555","article-title":"Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity","volume":"81","author":"Hew","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF155","article-title":"Review of HypoCCS data","author":"Hartman","year":"2001","journal-title":"Endo"},{"key":"10.1054\/ghir.2001.0263_RF156","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metab Clin Exp"},{"key":"10.1054\/ghir.2001.0263_RF157","first-page":"975","article-title":"The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis","volume":"79","author":"O'Neal","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF158","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1054\/ghir.1999.0091","article-title":"The effect of the deterioration of insulin sensitivity on -cell function in growth-hormone deficient adults following 4-month growth hormone replacement therapy","volume":"9","author":"Rosenfalck","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1054\/ghir.2001.0263_RF159","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metab Clin Exp"},{"key":"10.1054\/ghir.2001.0263_RF160","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficientadults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF161","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1365-2362.2000.00695.x","article-title":"The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy","volume":"30","author":"Riedl","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1054\/ghir.2001.0263_RF162","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years treatment with biosynthetic human growth hormone on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults","volume":"48","author":"Al-Shoumer","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF163","article-title":"Review of KIMS data","author":"Wilton","year":"2001","journal-title":"Endo"},{"key":"10.1054\/ghir.2001.0263_RF164","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metab Clin Exp"},{"key":"10.1054\/ghir.2001.0263_RF165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men","volume":"43","author":"De Boer","year":"1994","journal-title":"Metab Clin Exp"},{"key":"10.1054\/ghir.2001.0263_RF166","first-page":"2653","article-title":"Fasting and post prandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy","volume":"82","author":"Al-Shoumer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF167","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.13.2.296","article-title":"Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations","volume":"13","author":"Eden","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1054\/ghir.2001.0263_RF168","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1994.tb02555.x","article-title":"The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients","volume":"41","author":"Russell-Jones","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF169","first-page":"356","article-title":"The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF170","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF171","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficients adults. Influence of gender and Apo(a) and Apo(E) phenotypes","volume":"15","author":"Johansson","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1054\/ghir.2001.0263_RF172","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1340061","article-title":"An open 36 month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency","volume":"134","author":"Garry","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF173","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1054\/ghir.1999.0102","article-title":"The effect of 24 months recombinant human growth hormone (rhGH) on LDL cholesterol, triglyceride-rich lipoproteins and apo[a] in hypopituitary adults previously treated with conventional replacement therapy","volume":"9","author":"O'Neal","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1054\/ghir.2001.0263_RF174","first-page":"307","article-title":"Effects of growth hormone (GH) replacement therapy on very low density lipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study","volume":"84","author":"Christ","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.2000.01108.x","article-title":"Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study","volume":"53","author":"Florakis","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF176","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0021-9150(86)90099-7","article-title":"The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis","volume":"62","author":"Armstrong","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1054\/ghir.2001.0263_RF177","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1054\/ghir.2001.0263_RF178","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/eje.0.1360377","article-title":"Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein (a)","volume":"136","author":"Laron","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF179","first-page":"2410","article-title":"Continuous infusions versus daily injections of growth hormone for 4 weeks in GH-deficient patients","volume":"80","author":"Laursen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00041433-199405030-00002","article-title":"Growth hormone and hepatic lipoprotein metabolism","volume":"5","author":"Angelin","year":"1994","journal-title":"Cun Opin Lipidol"},{"key":"10.1054\/ghir.2001.0263_RF181","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/endo.131.6.1446613","article-title":"growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver","volume":"131","author":"Elam","year":"1992","journal-title":"Endocrinology"},{"key":"10.1054\/ghir.2001.0263_RF182","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/ghir.2001.0263_RF183","first-page":"2010","article-title":"Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency","volume":"82","author":"Cummings","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF184","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1992.tb02247.x","article-title":"Reactivity to stress and psychological adjustment in adults with pituitary insufficiency","volume":"6","author":"Stabler","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF185","first-page":"55","article-title":"Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency","volume":"356","author":"McGauley","year":"1989","journal-title":"Acta Paediatr Scand"},{"key":"10.1054\/ghir.2001.0263_RF186","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000181584","article-title":"Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency","volume":"131","author":"McGauley","year":"1990","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2001.0263_RF187","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","article-title":"Decreased psychological well-being in adult patients with growth hormone deficiency","volume":"40","author":"Rosen","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF188","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2265.1999.00802.x","article-title":"The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects","volume":"51","author":"Wallymahmed","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF189","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/jcem.80.12.8530603","article-title":"Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial","volume":"80","author":"Burman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF190","first-page":"3184","article-title":"Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency","volume":"83","author":"Baum","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF191","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-4530(86)90020-X","article-title":"Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study","volume":"11","author":"Almqvist","year":"1986","journal-title":"Psychoneuroendocrinology"},{"key":"10.1054\/ghir.2001.0263_RF192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(87)90438-1","article-title":"In situ hybridisation to rat brain and pituitary gland of growth hormone cDNA","volume":"79","author":"Gossard","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.1054\/ghir.2001.0263_RF193","first-page":"161","article-title":"Growth hormone: neurocrine and neuroendocrine perspectives","volume":"3","author":"Harvey","year":"1993","journal-title":"Growth Regul"},{"key":"10.1054\/ghir.2001.0263_RF194","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-8993(91)91485-J","article-title":"Characterisation of putative GH receptors in human choroid plexus","volume":"546","author":"Lai","year":"1991","journal-title":"Brain Res"},{"key":"10.1054\/ghir.2001.0263_RF195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000126813","article-title":"Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters","volume":"61","author":"Johansson","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1054\/ghir.2001.0263_RF196","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2265.1996.617439.x","article-title":"Growth hormone affects brain transmitters and thyroxine","volume":"44","author":"Burman","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF197","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000125320","article-title":"Growth hormone deficient young adults have decreased deep sleep","volume":"51","author":"\u00c5str\u00f6m","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1054\/ghir.2001.0263_RF198","first-page":"496","article-title":"The influence of growth hormone on sleep in adults with growth hormone deficiency","volume":"33","author":"\u00c5str\u00f6m","year":"1990","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF199","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.1995.tb02688.x","article-title":"Characteristics of adults who wish to enter a trial of growth hormone replacement","volume":"42","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF200","first-page":"1905","article-title":"The \u201cQuality of Life-Assessment of Growth Hormone Deficiency in Adults\u201d questionnaire: can it be used to assess quality of life in hypopituitarism?","volume":"86","author":"Barkan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2265.1996.671492.x","article-title":"The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood","volume":"44","author":"Nicholson","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF202","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2265.1996.00850.x","article-title":"Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth","volume":"45","author":"Wacharasindu","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF203","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1210\/jcem.82.7.4101","article-title":"Why retest adults with childhood-onset growth hormone deficiency?","volume":"82","author":"de Boer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jcem.82.2.3726","article-title":"Growth hormone retesting and auxological data in 131 GH-deficienct patients after completion of treatment","volume":"82","author":"Tauber","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF205","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth-hormone deficiency in adults","volume":"30","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"key":"10.1054\/ghir.2001.0263_RF206","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two year placebo-controlled study","volume":"85","author":"Vahl","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF207","first-page":"4516","article-title":"Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects","volume":"84","author":"Johannsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF208","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1210\/jcem.85.5.6613","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism","volume":"85","author":"N\u00f8rrelund","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF209","article-title":"GH continuation enhances whilst cessation arrests bone mineralisation in adolescents with GH deficiency at completion of linear growth","author":"Drake","year":"2001","journal-title":"Endo"},{"key":"10.1054\/ghir.2001.0263_RF210","doi-asserted-by":"crossref","unstructured":"Wiren, L. Johannsson, G. Bengtsson, B.-A. A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood, J. Clin Endocrinol Metab, 86, 3494, 3498","DOI":"10.1210\/jc.86.8.3494"},{"key":"10.1054\/ghir.2001.0263_RF211","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI110164","article-title":"Impaired growth hormone secretion in the adult population: relation to age and adiposity","volume":"67","author":"Rudman","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1054\/ghir.2001.0263_RF212","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretary bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF213","first-page":"460","article-title":"Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years","volume":"81","author":"Toogood","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF214","first-page":"2215","article-title":"Preservation of growth hormone pulsatility despite pituitary pathology, surgery and irradiation","volume":"82","author":"Toogood","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2265.1998.00440.x","article-title":"The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease","volume":"48","author":"Toogood","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF216","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2265.1996.8310842.x","article-title":"Body composition in growth hormone-deficiency in adults over the age of 60 years","volume":"45","author":"Toogood","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF217","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem.84.1.5408","article-title":"Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose finding study","volume":"84","author":"Toogood","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF218","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.2000.01104.x","article-title":"Growth hormone deficiency and replacement in growth hormone deficient adults","volume":"53","author":"Monson","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF219","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.1972.tb00397.x","article-title":"Skin collagen and thickness in acromegaly and hypopituitarism","volume":"1","author":"Black","year":"1972","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199007053230101","article-title":"Effects of human growth hormone in men over 60 years old","volume":"323","author":"Rudman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2001.0263_RF221","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1260467","article-title":"Localization of the growth hormone receptor\/binding protein in skin","volume":"126","author":"Lobie","year":"1990","journal-title":"J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF222","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(89)90930-6","article-title":"Reduced sweating in adults with growth hormone deficiency","volume":"ii","author":"Pedersen","year":"1989","journal-title":"Lancet"},{"key":"10.1054\/ghir.2001.0263_RF223","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2265.1993.tb01001.x","article-title":"Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise","volume":"38","author":"Juul","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF224","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1677\/joe.0.0890275","article-title":"Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters","volume":"89","author":"Holder","year":"1981","journal-title":"J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1203\/00006450-198609000-00002","article-title":"Biosynthestic somatomedin C increases the length and weight of Snell dwarf mice","volume":"20","author":"Van Buul-Offers","year":"1986","journal-title":"Paediatr Res"},{"key":"10.1054\/ghir.2001.0263_RF226","first-page":"58","article-title":"Alterations of monocyte function in parents with growth hormone (GH) deficiency: effect of substitutive GH therapy","volume":"84","author":"Serri","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF227","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(87)80579-6","article-title":"Effect of growth hormone therapy on immune function","volume":"110","author":"Ammann","year":"1987","journal-title":"J Paediatr"},{"key":"10.1054\/ghir.2001.0263_RF228","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3476(05)80737-1","article-title":"Immunologic studies in Turner syndrome before and during treatment with growth hormone","volume":"119","author":"Rongen-Westerlaken","year":"1991","journal-title":"J Paediatr"},{"key":"10.1054\/ghir.2001.0263_RF229","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000182708","article-title":"Immunological findings in growth hormone treated patients","volume":"39","author":"Wit","year":"1993","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2001.0263_RF230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000233009","article-title":"Regulation of natural killer activity in vivo III. Effect of hypophysectomy and growth hormone treatment on he natural killer activity of the mouse spleen population","volume":"67","author":"Saxena","year":"1982","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1054\/ghir.2001.0263_RF231","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3476(05)80697-3","article-title":"In vitro and in vivo effect of growth hormone on cytotoxic activity","volume":"117","author":"Bozzola","year":"1990","journal-title":"J Paediatr"},{"key":"10.1054\/ghir.2001.0263_RF232","first-page":"43","article-title":"Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled trials","volume":"1","author":"M\u00e5rdh","year":"1994","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF233","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1530\/eje.0.1370146","article-title":"The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults","volume":"137","author":"Carroll","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF234","first-page":"223","article-title":"Serum insulinlike growth factor-I (IGF-I), IGF binding protein-1 and \u22121, and the acid labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency","volume":"82","author":"Th\u00f3ren","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF235","first-page":"744","article-title":"Serum IGF-I in 1030 healthy children, adolescents and adults; relation to age, sex, stage of puberty, testicular size and body mass index","volume":"78","author":"Juul","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF236","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers","volume":"81","author":"De Boer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF237","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-64-1-51","article-title":"Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations","volume":"64","author":"Ho","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF238","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jcem-70-5-1375","article-title":"Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy","volume":"70","author":"Hartman","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF239","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI2908","article-title":"Regulatory mechanisms of growth hormone secretion are sexually dimorphic","volume":"102","author":"Jaffe","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1054\/ghir.2001.0263_RF240","first-page":"2460","article-title":"The amplitude-specific divergence in the pulsatile mode of growth hormone (GH) underlies gender differences in mean GH concentration in men and premenopausal women","volume":"81","author":"Van den Berg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF241","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2265.1992.tb02270.x","article-title":"Pulsatile growth hormone release in normal women during the menstrual cycle","volume":"36","author":"Faria","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF242","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jcem.83.5.4761","article-title":"Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during periovulatory period in normal women","volume":"83","author":"Ovesen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF243","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jcem-63-2-424","article-title":"Regulation of growth hormone and somatomedin-C secretion in postmenopausal women\u2014effect of physiological estrogen replacement","volume":"63","author":"Dawson-Hughes","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF244","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-72-2-374","article-title":"Contrasting effects of oral and transdermal routes of oestrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I and GH-binding protein in post-menopausal women","volume":"72","author":"Weissberger","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF245","first-page":"129","article-title":"A low starting dose of genotropin in growth hormone deficient adults","volume":"82","author":"Janssen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF246","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement than women","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF247","first-page":"2002","article-title":"Gender differences in the effects of long term growth hormone (GH) treatment on bones in adults with GH deficiency","volume":"84","author":"Johansson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF248","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/jcem.85.3.6463","article-title":"Gender difference in insulin-like growth factor-I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement","volume":"85","author":"Span","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF249","first-page":"464","article-title":"A switch from oral (2mg\/day) to transdermal (50 \u03bcg\/day) 17-beta-estradiol therapy increases serum insulin-like growth factor I levels in recombinant growth hormone (GH) substituted women with growth hormone deficiency","volume":"85","author":"Janssen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF250","first-page":"1918","article-title":"Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex","volume":"85","author":"Kam","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF251","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualised dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"5","author":"Johannsson","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF252","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimising growth hormone replacement therapy by dose titration in hypopituitary adults","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF253","first-page":"379","volume":"82","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF254","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/jme.0.0090257","article-title":"Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic IGF-I mRNA levels in the diabetic rat: a functional role for the portal vascular link","volume":"9","author":"Russell-Jones","year":"1992","journal-title":"J Mol Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF255","first-page":"124","article-title":"Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males","volume":"85","author":"Wallace","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF256","first-page":"1505","article-title":"Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group","volume":"85","author":"Longobardi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF257","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1995.tb01908.x","article-title":"Which adults develop side-effects of growth hormone replacement?","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF258","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0889-8529(18)30204-4","article-title":"Clinical manifestations of acromegaly","volume":"21","author":"Molitch","year":"1992","journal-title":"Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF259","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1212\/WNL.25.7.638","article-title":"Neuromuscular complications of acromegaly","volume":"25","author":"Pickett","year":"1975","journal-title":"Neurology"},{"key":"10.1054\/ghir.2001.0263_RF260","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.2.6041.914","article-title":"Muscle changes in acrome","volume":"2","author":"Nagulesparen","year":"1976","journal-title":"Br Med J"},{"key":"10.1054\/ghir.2001.0263_RF261","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0889-8529(18)30205-6","article-title":"Rheumatologic and skeletal changes in acromegaly","volume":"21","author":"Liebermann","year":"1992","journal-title":"Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF262","first-page":"1693","article-title":"Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967\u20131992. The Canadian Growth Hormone Advisory Committee","volume":"81","author":"Taback","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF263","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0022-3476(96)70002-1","article-title":"Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience","volume":"128","author":"Moshang","year":"1996","journal-title":"J Paediatr"},{"key":"10.1054\/ghir.2001.0263_RF264","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/bmj.302.6780.824","article-title":"Mortality, neoplasia and Creutzfeld\u2013Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom","volume":"302","author":"Buchanan","year":"1991","journal-title":"Br Med J"},{"key":"10.1054\/ghir.2001.0263_RF265","first-page":"1704","article-title":"Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study Experience","volume":"81","author":"Blethen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF266","first-page":"4444","article-title":"Growth hormone treatment of children with brain tumors and risk of tumor recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2001.0263_RF267","article-title":"Prospective multicenter safety surveillance of GH replacement in 2033 GH-deficient adults","author":"Hartman","year":"2001","journal-title":"ENDO"},{"key":"10.1054\/ghir.2001.0263_RF268","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2265.1993.tb02386.x","article-title":"Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters","volume":"39","author":"M\u00f8ller","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF269","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1054\/ghir.2001.0263_RF270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM199308263290917","article-title":"Growth hormone, insulin-like growth factor-I, and benign intracranial hypertension","volume":"329","author":"Malozowski","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2001.0263_RF271","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2265.1993.tb02388.x","article-title":"Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations","volume":"39","author":"Cohn","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.2001.0263_RF272","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00019053-199814040-00006","article-title":"The burden of illness of hypopituitary adults with growth hormone deficiency","volume":"14","author":"Hakkaart-van","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1054\/ghir.2001.0263_RF273","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00019053-200017060-00008","article-title":"Cost of illness in adult patients with hypopituitarism","volume":"17","author":"Ehrnborg","year":"2000","journal-title":"Pharmacoeconomics"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637401902631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637401902631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:39:20Z","timestamp":1761086360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637401902631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":273,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S1096637401902631"],"URL":"https:\/\/doi.org\/10.1054\/ghir.2001.0263","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone replacement therapy for adults: Into the new millennium","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1054\/ghir.2001.0263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}